Gene · 8322
Papers2,273
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,273
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications. | Nat Rev Cardiol | 2022 | 35697779 | PubTator, text mining | PubMed |
Secreted Amyloid Precursor Protein Alpha, a Neuroprotective Protein in the Brain Has Widespread Effects on the Transcriptome and Proteome of Human Inducible Pluripotent Stem Cell-Derived Glutamatergic Neurons Related to Memory Mechanisms. | Front Neurosci | 2022 | 35692428 | PubTator, text mining | PubMed |
| Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC. | Cancers (Basel) | 2022 | 35681606 | PubTator, text mining | PubMed |
| Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses. | Annu Rev Virol | 2022 | 35671566 | PubTator, text mining | PubMed |
| In Ovo Injection of CHIR-99021 Promotes Feather Follicle Development via Modulating the Wnt Signaling Pathway and Transcriptome in Goose Embryos (Anser cygnoides). | Front Physiol | 2022 | 35669574 | PubTator, text mining | PubMed |
| Ocular manifestations of Chinese patients with copy number variants in the NDP gene. | Mol Vis | 2022 | 35656167 | PubTator, text mining | PubMed |
| Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial. | Sci Rep | 2022 | 35654932 | PubTator, text mining | PubMed |
| The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. | Front Cell Dev Biol | 2022 | 35652090 | PubTator, text mining | PubMed |
| Spectrum of Mutations in NDP Resulting in Ocular Disease; a Systematic Review. | Front Genet | 2022 | 35651932 | PubTator, text mining | PubMed |
| An integrated model for Gpr124 function in Wnt7a/b signaling among vertebrates. | Cell Rep | 2022 | 35649360 | PubTator, text mining | PubMed |
| Vangl as a Master Scaffold for Wnt/Planar Cell Polarity Signaling in Development and Disease. | Front Cell Dev Biol | 2022 | 35646914 | PubTator, text mining | PubMed |
| Affinity Proteomics Identifies Interaction Partners and Defines Novel Insights into the Function of the Adhesion GPCR VLGR1/ADGRV1. | Molecules | 2022 | 35630584 | PubTator, text mining | PubMed |
| IFNγ-Treated Macrophages Induce EMT through the WNT Pathway: Relevance in Crohn's Disease. | Biomedicines | 2022 | 35625832 | PubTator, text mining | PubMed |
| Biomarkers as Predictive Factors of Anti-VEGF Response. | Biomedicines | 2022 | 35625740 | PubTator, text mining | PubMed |
| Retraction Notice to: Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC. | Mol Ther Nucleic Acids | 2022 | 35615007 | PubTator, text mining | PubMed |
| Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma. | Bioengineered | 2022 | 35609322 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. | MedComm (2020) | 2022 | 35601657 | PubTator, text mining | PubMed |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. | Biomed Res Int | 2022 | 35601155 | PubTator, text mining | PubMed |
| LINC01232 Promotes Metastasis and EMT by Regulating miR-506-5p/PAK1 Axis in Gastric Cancer. | Cancer Manag Res | 2022 | 35592108 | PubTator, text mining | PubMed |
| The effect of melatonin on the mouse ameloblast-lineage cell line ALCs. | Sci Rep | 2022 | 35581244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8322/papers?page=25